Daxor Total Current Liabilities vs Non Current Liabilities Total Analysis

DXR Stock

USD 9.50 0.18 1.86%

Daxor financial indicator trend analysis is much more than just examining Daxor latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Daxor is a good investment. Please check the relationship between Daxor Total Current Liabilities and its Non Current Liabilities Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Daxor. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in Daxor Stock, please use our How to Invest in Daxor guide.

Total Current Liabilities vs Non Current Liabilities Total

Total Current Liabilities vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Daxor Total Current Liabilities account and Non Current Liabilities Total. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Daxor's Total Current Liabilities and Non Current Liabilities Total is -0.21. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Daxor, assuming nothing else is changed. The correlation between historical values of Daxor's Total Current Liabilities and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Daxor are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Current Liabilities i.e., Daxor's Total Current Liabilities and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Daxor balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Daxor are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Current Liabilities Total

Most indicators from Daxor's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Daxor current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Daxor. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in Daxor Stock, please use our How to Invest in Daxor guide.At this time, Daxor's Sales General And Administrative To Revenue is relatively stable compared to the past year. As of 05/24/2024, Enterprise Value Over EBITDA is likely to grow to 143.98, while Selling General Administrative is likely to drop slightly above 292 K.

	2023	2024 (projected)
Research Development	3.1M	1.8M
Cost Of Revenue	177.1K	168.2K

Research Development Cost Of Revenue

Daxor fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Other Current Liab	Total Current Liabilities	Accounts Payable	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Other Current Assets	Treasury Stock
Total Assets		0.66	0.85	0.25	0.68	0.49	-0.21	0.28	-0.93	0.76	-0.21	0.73	0.13	0.26	0.44	0.87	0.68	0.73	0.73	0.51	0.25	0.13	0.13	0.21	0.78	-0.03
Short Long Term Debt Total	0.66		0.42	0.0	0.89	-0.05	0.05	0.61	-0.71	0.11	0.05	0.27	0.01	0.84	0.68	0.76	0.23	0.26	0.25	0.01	-0.01	0.55	0.55	-0.19	0.39	-0.34
Total Stockholder Equity	0.85	0.42		0.39	0.52	0.73	-0.3	0.48	-0.88	0.62	-0.3	0.42	0.24	0.12	0.09	0.51	0.35	0.43	0.42	0.27	0.4	-0.03	-0.03	0.52	0.44	0.13
Property Plant And Equipment Net	0.25	0.0	0.39		0.44	0.55	-0.96	0.41	-0.49	0.19	-0.96	0.03	-0.63	-0.04	-0.36	0.04	-0.16	0.05	0.04	-0.35	1.0	0.08	0.08	0.8	0.05	-0.59
Net Debt	0.68	0.89	0.52	0.44		0.22	-0.4	0.72	-0.83	0.17	-0.4	0.26	-0.28	0.73	0.44	0.7	0.14	0.26	0.25	-0.14	0.43	0.49	0.49	0.15	0.37	-0.59
Retained Earnings	0.49	-0.05	0.73	0.55	0.22		-0.59	0.24	-0.57	0.53	-0.59	0.37	0.08	-0.33	-0.38	0.21	0.26	0.38	0.38	0.21	0.55	-0.37	-0.37	0.59	0.29	0.04
Cash	-0.21	0.05	-0.3	-0.96	-0.4	-0.59		-0.29	0.42	-0.21	1.0	-0.14	0.65	0.13	0.38	-0.08	0.05	-0.15	-0.14	0.26	-0.96	0.02	0.02	-0.68	-0.13	0.61
Non Current Assets Total	0.28	0.61	0.48	0.41	0.72	0.24	-0.29		-0.57	-0.27	-0.29	-0.35	-0.1	0.69	0.08	0.12	-0.45	-0.35	-0.36	-0.61	0.41	0.42	0.42	0.33	-0.25	-0.38
Non Currrent Assets Other	-0.93	-0.71	-0.88	-0.49	-0.83	-0.57	0.42	-0.57		-0.57	0.42	-0.52	0.03	-0.4	-0.31	-0.76	-0.41	-0.52	-0.51	-0.2	-0.49	-0.23	-0.23	-0.39	-0.59	0.24
Other Assets	0.76	0.11	0.62	0.19	0.17	0.53	-0.21	-0.27	-0.57		-0.21	0.89	0.26	-0.3	0.17	0.66	0.86	0.89	0.89	0.81	0.2	-0.21	-0.21	0.34	0.85	0.2
Cash And Short Term Investments	-0.21	0.05	-0.3	-0.96	-0.4	-0.59	1.0	-0.29	0.42	-0.21		-0.14	0.65	0.13	0.38	-0.08	0.05	-0.15	-0.14	0.26	-0.96	0.02	0.02	-0.68	-0.13	0.61
Net Receivables	0.73	0.27	0.42	0.03	0.26	0.37	-0.14	-0.35	-0.52	0.89	-0.14		0.16	-0.19	0.37	0.83	0.98	1.0	1.0	0.84	0.03	-0.13	-0.13	-0.05	0.98	0.04
Common Stock Shares Outstanding	0.13	0.01	0.24	-0.63	-0.28	0.08	0.65	-0.1	0.03	0.26	0.65	0.16		-0.09	0.18	0.1	0.29	0.16	0.16	0.46	-0.63	-0.18	-0.18	-0.17	0.13	0.75
Non Current Liabilities Total	0.26	0.84	0.12	-0.04	0.73	-0.33	0.13	0.69	-0.4	-0.3	0.13	-0.19	-0.09		0.44	0.35	-0.21	-0.21	-0.21	-0.36	-0.04	0.75	0.75	-0.18	-0.06	-0.35
Other Stockholder Equity	0.44	0.68	0.09	-0.36	0.44	-0.38	0.38	0.08	-0.31	0.17	0.38	0.37	0.18	0.44		0.66	0.42	0.36	0.36	0.27	-0.37	0.17	0.17	-0.45	0.49	-0.18
Total Liab	0.87	0.76	0.51	0.04	0.7	0.21	-0.08	0.12	-0.76	0.66	-0.08	0.83	0.1	0.35	0.66		0.79	0.82	0.82	0.56	0.03	0.25	0.25	-0.14	0.9	-0.2
Total Current Assets	0.68	0.23	0.35	-0.16	0.14	0.26	0.05	-0.45	-0.41	0.86	0.05	0.98	0.29	-0.21	0.42	0.79		0.98	0.98	0.91	-0.16	-0.15	-0.15	-0.17	0.96	0.18
Other Current Liab	0.73	0.26	0.43	0.05	0.26	0.38	-0.15	-0.35	-0.52	0.89	-0.15	1.0	0.16	-0.21	0.36	0.82	0.98		1.0	0.84	0.04	-0.13	-0.13	-0.03	0.98	0.04
Total Current Liabilities	0.73	0.25	0.42	0.04	0.25	0.38	-0.14	-0.36	-0.51	0.89	-0.14	1.0	0.16	-0.21	0.36	0.82	0.98	1.0		0.85	0.04	-0.14	-0.14	-0.04	0.98	0.05
Accounts Payable	0.51	0.01	0.27	-0.35	-0.14	0.21	0.26	-0.61	-0.2	0.81	0.26	0.84	0.46	-0.36	0.27	0.56	0.91	0.84	0.85		-0.35	-0.34	-0.34	-0.19	0.77	0.5
Property Plant And Equipment Gross	0.25	-0.01	0.4	1.0	0.43	0.55	-0.96	0.41	-0.49	0.2	-0.96	0.03	-0.63	-0.04	-0.37	0.03	-0.16	0.04	0.04	-0.35		0.08	0.08	0.8	0.05	-0.58
Common Stock Total Equity	0.13	0.55	-0.03	0.08	0.49	-0.37	0.02	0.42	-0.23	-0.21	0.02	-0.13	-0.18	0.75	0.17	0.25	-0.15	-0.13	-0.14	-0.34	0.08		1.0	-0.07	0.01	-0.35
Common Stock	0.13	0.55	-0.03	0.08	0.49	-0.37	0.02	0.42	-0.23	-0.21	0.02	-0.13	-0.18	0.75	0.17	0.25	-0.15	-0.13	-0.14	-0.34	0.08	1.0		-0.07	0.01	-0.35
Short Term Investments	0.21	-0.19	0.52	0.8	0.15	0.59	-0.68	0.33	-0.39	0.34	-0.68	-0.05	-0.17	-0.18	-0.45	-0.14	-0.17	-0.03	-0.04	-0.19	0.8	-0.07	-0.07		-0.07	-0.14
Other Current Assets	0.78	0.39	0.44	0.05	0.37	0.29	-0.13	-0.25	-0.59	0.85	-0.13	0.98	0.13	-0.06	0.49	0.9	0.96	0.98	0.98	0.77	0.05	0.01	0.01	-0.07		-0.07
Treasury Stock	-0.03	-0.34	0.13	-0.59	-0.59	0.04	0.61	-0.38	0.24	0.2	0.61	0.04	0.75	-0.35	-0.18	-0.2	0.18	0.04	0.05	0.5	-0.58	-0.35	-0.35	-0.14	-0.07

Click cells to compare fundamentals

Daxor Account Relationship Matchups

Daxor fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.2M	16.6M	25.0M	30.3M	34.9M	46.0M
Short Long Term Debt Total	1.3M	170.7K	3.0M	1.2M	755.7K	717.9K
Total Stockholder Equity	12.8M	15.7M	21.2M	29.0M	34.0M	31.3M
Net Debt	1.3M	(447.1K)	2.3M	1.2M	755.7K	717.9K
Retained Earnings	16.6M	14.9M	19.6M	24.8M	25.1M	18.0M
Non Current Assets Total	14.0M	15.7M	24.2M	30.2M	34.8M	17.7M
Non Currrent Assets Other	(14.0M)	(15.7M)	(24.2M)	(30.2M)	(34.8M)	(36.6M)
Other Assets	198.5K	851.7K	733.8K	20.6K	34.9M	26.2M
Net Receivables	32.7K	29.3K	30.7K	17.2K	14.2K	13.5K
Common Stock Shares Outstanding	3.7M	3.9M	4.0M	4.1M	4.6M	3.7M
Liabilities And Stockholders Equity	14.2M	16.6M	25.0M	30.3M	34.9M	46.0M
Non Current Liabilities Total	1.3M	170.7K	3.0M	1.3M	858.8K	815.8K
Other Stockholder Equity	(20.4M)	(14.1M)	(18.1M)	(20.7M)	(16.2M)	(15.4M)
Total Liab	1.4M	877.7K	3.8M	1.3M	858.8K	815.8K
Total Current Assets	32.7K	29.3K	30.7K	17.2K	25.9K	24.6K
Other Current Liab	(72.5K)	(78.8K)	(80K)	(87.4K)	(100.5K)	(95.5K)
Total Current Liabilities	78.8K	80K	87.4K	62.4K	103.1K	97.9K
Accounts Payable	78.8K	80K	87.4K	62.4K	103.1K	146.9K
Short Term Debt	4.5M	1.3M	627K	715.8K	823.2K	782.0K
Net Tangible Assets	12.8M	15.7M	21.2M	29.0M	26.1M	19.4M
Capital Surpluse	10.8M	10.9M	11.1M	11.4M	13.2M	12.0M
Long Term Investments	14.0M	15.7M	24.2M	30.2M	34.8M	25.9M
Net Invested Capital	14.1M	15.8M	24.2M	30.2M	34.8M	24.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Daxor is a strong investment it is important to analyze Daxor's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Daxor's future performance. For an informed investment choice regarding Daxor Stock, refer to the following important reports:

How To Invest In Daxor

Details

Is Daxor Stock a good investment?

Details

What is Daxor's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Daxor. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

To learn how to invest in Daxor Stock, please use our How to Invest in Daxor guide.

You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Daxor Stock analysis

When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world

Is Daxor's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Daxor. If investors know Daxor will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Daxor listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.58)

Earnings Share

0.14

Revenue Per Share

0.034

Quarterly Revenue Growth

(0.14)

Return On Assets

(0.02)

The market value of Daxor is measured differently than its book value, which is the value of Daxor that is recorded on the company's balance sheet. Investors also form their own opinion of Daxor's value that differs from its market value or its book value, called intrinsic value, which is Daxor's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Daxor's market value can be influenced by many factors that don't directly affect Daxor's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Daxor's value and its price as these two are different measures arrived at by different means. Investors typically determine if Daxor is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Daxor's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Daxor Total Current Liabilities vs Non Current Liabilities Total Analysis

Total Current Liabilities vs Non Current Liabilities Total

Total Current Liabilities vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Non Current Liabilities Total

Daxor fundamental ratios Correlations

Daxor Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Daxor fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Daxor Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Other Current Liab	+ 1.0	Net Receivables
Total Current Liabilities	+ 1.0	Net Receivables
Total Current Liabilities	+ 1.0	Other Current Liab
Common Stock	+ 1.0	Common Stock Total Equity

Property Plant And Equipment Gross	- 0.96	Cash And Short Term Investments
Property Plant And Equipment Gross	- 0.96	Cash
Cash And Short Term Investments	- 0.96	Property Plant And Equipment Net
Cash	- 0.96	Property Plant And Equipment Net
Non Currrent Assets Other	- 0.93	Total Assets
Non Currrent Assets Other	- 0.88	Total Stockholder Equity